Hemoperitoneum is an initial presentation of recurrent granulosa cell tumors of the ovary

Japanese Journal of Clinical Oncology

Volumn 29, Issue 10, 1999, Pages 509-512

  Lee, Wen Ling ^b   Yuan, Chiou Chung ^b   Lai, Chung Ru ^b   Wang, Peng Hui ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Acute abdomen; Granulosa cell tumors of the ovary; Hemoperitoneum; Ruptured ovarian tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CISCA PROTOCOL; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ACUTE ABDOMEN; ADULT; CASE REPORT; FEMALE; GRANULOSA CELL TUMOR; HEMOPERITONEUM; HUMAN; MULTIMODALITY CANCER THERAPY; OVARIECTOMY; OVARY TUMOR; PATHOLOGY; REVIEW; TUMOR RECURRENCE;

ABDOMEN, ACUTE; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; GRANULOSA CELL TUMOR; HEMOPERITONEUM; HUMANS; NEOPLASM RECURRENCE, LOCAL; OVARIAN NEOPLASMS; OVARIECTOMY;

EID: 0033201802     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/29.10.509     Document Type: Article

References (49)

1. Hartmann LC, Young RH, Evans MP, Podratz KC. Ovarian sex cord-stromal tumors. In: Hoskins WJ, Perez CA, Young RC, editors. Principles and Practice of Gynecologic Oncology, 2nd ed. Philadelphia: Lippincott-Raven 1997;1003-24.
2. Anikwue C, Dawood MY, Kramer E. Granulosa and theca cell tumors. Obstet Gynecol 1978;51:214-20.
3. Asschenfeldt P, Thind P. Granulosa cell tumor. A case with primary peritoneal carcinomatosis and recurrence after 24 years. Ugeskr Laeger 1984;146:1938.
4. Costa MJ, Walls J, Ames P, Roth LM. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior. Hum Pathol 1996;27:274-81.
5. Evans AT, Gaffey TA, Malkasian GD, Annegers JF. Clinicopathologic review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 1980;55:231-8.
6. Fox H, Langley FA. A clinicopathological study of 92 cases of granulosa cell tumors of the ovary with special reference to factors influencing prognosis. Cancer 1975;35:231-41.
7. Mines JF, Khalifa MA, Moore JL, Fine KP, Lage JM, Barnes WA. Recurrent granulosa cell tumor of the ovary 37 years after initial diagnosis: a case report and review of the literature. Gynecol Oncol 1996;60:484-8.
8. Hitchcock CL, Norris HJ, Khalifa MA, Wargotz ES. Flow cytometric analysis of granulosa tumors. Cancer 1989;46:2127-32.
9. Li MK, van der Walt JD. Recurrent granulosa cell tumor of the ovary 22 years after primary excision. J R Coll Surg Edinb 1984;29:192-4.
10. Lusch CJ, Mercurio TM, Runyeon WK. Delayed recurrence and chemotherapy of a granulosa cell tumor. Obstet Gynecol 1978;51:505-7.
11. Malmstrom H, Hogberg T, Risberg B, Simonsen E. Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol 1994;52:50-5.
12. Miller BE, Barron BA, Wan JY, Delmore JE, Silva EG, Gershenson DM. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer 1997;79:1951-9.
13. Pal SK, Chowdhury NN. Late recurrence of granulosa cell tumor. Asia Ocean J Obstet Gynecol 1986;12:21-3.
14. Pankratz E, Boyes DA, White GW, Galliford BW, Fairey RN, Benedet JL. Granulosa cell tumors. A clinical review of 61 cases. Obstet Gynecol 1978;52:718-23.
15. Piura B, Nemet D, Yanai-Inbar I, Cohen Y, Glezerman M. Granulosa-cell tumor of the ovary: a study of 18 cases. J Surg Oncol 1994;55:71-7.
16. Sommers SC, Gates O, Goodoe II. Late recurrence of granulosa cell tumor. A report of two cases. Obstet Gynecol 1955;6:395-8.
17. Stage AH, Grafton WD. Thecomas and granulosa-theca cell tumors of the ovary: an analysis of 51 tumors. Obstet Gynecol 1977;50:21-7.
18. Stenwig JT, Hazekamp JT, Beecham JB. Granulosa cell tumors of the ovary: a clinicopathological study of 118 cases with long-term follow-up. Gynecol Oncol 1979;7:136-52.
19. Colombo N. Management of sex cord-stromal tumors. In: Gershenson DM, McGuire WP, editors. Ovarian Cancer: Controversies in Management. New York: Churchill Livingstone 1998;417-24.
20. Aboud E. Adult granulosa cell tumors of the ovary. Eur J Gynecol Oncol 1997;18:520-2.
21. Fontanelli R, Stefanon B, Raspagliesi F, Kenda R, Tomasic G, Spatti G, et al. Adult granulosa cell tumors of the ovary: a clinico-pathological study of 35 cases. Tumori 1998;84:60-4.
22. Ohel G, Kaneti H, Schenker JG. Granulosa cell tumors in Israel: a study of 172 cases. Gynecol Oncol 1983;15:278-86.
23. Chang CY, Yeh WR, Chao KC, Ng HT. Granulosa cell tumor of the ovary. Chung Hua I Hsueh Tsa Chih 1990;46:172-6.
24. French WG. The clinical behavior of granulosa-cell tumor of the ovary. Am J Obstet Gynecol 1951;62:75-82.
25. Von Friesen B. Spontaneous rupture on ovarian tumor, granulosa cell tumor. Acta Obstet Gynecol Scand 1944;24:8-28.
26. Charters JW, Prince G, McGarry JM. Granulosa cell tumor presenting with haemoperitoneum and splenic rupture. Br J Obstet Gynecol 1989;96:735-6.
27. Gondos B, Monroe SA. Cystic granulosa cell tumor with massive haemoperitoneum. Obstet Gynecol 1971;38:683-9.
28. Poma A. Hemoperitoneum in a postmenopausal woman. J Natl Med Assoc 1998;90:317-19.
29. Bjorkholm E, Petterson F. Granulosa cell and theca cell tumors: the clinical picture and long term outcome for the Radiumhemmet series. Acta Obstet Gynecol Scand 1980;59:361.
30. Wabersich J, Fracas M, Mazzer S, Marcheur M, Altavilla G. The value of prognostic factors in ovarian granulosa cell tumor. Eur J Gynecol Oncol 1998;19:69-72.
31. Boggess JF, Soules MR, Goff BA, Greer BE, Cain JM, Tamimi HK. Serum inhibin and disease status in women with ovarian granulosa cell tumors. Gynecol Oncol 1997;64:64-9.
32. Ala-Fossi SL, Maenpaa J, Aline R, Koivisto P, Koivisto AM, Punnonen R. Prognostic significance of p53 expression in ovarian granulosa cell tumors. Gynecol Oncol 1997;66:475-9.
33. DiSaia PJ, Creasman WT. Germ cell, stromal and other ovarian tumors. In: DiSaia PJ, Creasman WT, editors. Clinical Gynecologic Oncology, 5th ed. St Louis: Mosby Year Book 1997;351-74.
34. Schwanz PE, Smith JP. Treatment of ovarian stromal tumors. Am J Obstet Gynecol 1976;125:402-7.
35. Jacob HJ, Deppe G, Cohen CJ. Combination chemotherapy of ovarian granulosa cell tumor with cisplatin and doxorubicin. Gynecol Oncol 1982;14:294-301.
36. Canlibel F, Caputo TA. Chemotherapy of granulosa cell tumors. Am J Obstet Gynecol 1983;145:763-9.
37. Gershenson DM, Copeland LJ, Kavanaugh JJ. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin and cyclophosphamide. Obstet Gynecol 1987;70:765-9.
38. Pectasides D, Alevizakos N, Athanassiou AE. Cisplatin-containing regimen in advanced or recurrent granulosa cell tumors of the ovary. Ann Oncol 1992;3:316-20.
39. Slayton RE. Management of germ cell and stromal tumors of the ovary. Semin Oncol 1984;11:299-302.
40. Colombo N, Sessa C, Landoni F. Cisplatin, vinblastine and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol 1986;67:265-8.
41. Chiara S, Merlini L, Campora E, Bruzzone M, Gindici S, Rosso R, Ragni N. Cisplatin-based chemotherapy in recurrent or high risk ovarian granulosa cell tumor patients. Eur J Gynecol Oncol 1993;14:314-17.
42. Zambetti M, Escobedo A, Pilotti S, DePaLo G. Cisplatin/vinbalstin/bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol 1990;36:317-21.
43. Homesley HD, Bunday BN, Hurteau JA, Roth LM. Bleomycin, etoposide and cisplatin combination therapy of ovarian granulosa cell tumors and other stromal malignancies: a Gynecologic Oncology Group study. Gynecol Oncol 1999;72:131-7.
44. Kammerman S, Demopoulos RI, Raphael C, Ross J. Gonadotropic hormone binding to human ovarian tumors. Hum Pathol 1981;12:886-91.
45. Emons G, Pahwa GS, Ortmann O, Brack C. LHRH-receptors and LHRH-agonist treatment in ovarian cancer: an overview. J Steroid Biochem Mol Biol 1990;37:1003-6.
46. Fishman A, Kudelka AP, Tresukosal D, Edwards CL, Freedman RS, Kaplan AL. Leuprolide acetate for treating refractory or persistent ovarian granulosa cell tumor. J Reprod Med 1996;41:393-6.
47. Wang PH, Chao HT, Lee WL. Treatment of steroid cell tumors of the ovary by long-acting gonadotropin releasing hormone agonist. Fertil Steril 1998;69:353-5.
48. Chao HT, Wang PH, Lin HD. Gonadotropin-releasing hormone-agonist is used a neoadjuvant therapy for Sertoli-Leydig cell tumors of the ovary. Int J Gynecol Obstet 1999.
49. Lee WL, Wang PH, Tseng HS, Lin HD, Yuan CC, Chao HT. Managing a patient with presumed testosterone-secreting ovarian tumor. Gynecol Oncol 1999;74.